{
    "SPADE_N_14073": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14073",
            "Peptide Name": "PN7 (Plectasin D9Y,M13G,Q14R, plectasin analog, synthetic AMPs, 3S=S, UCSS1a)",
            "Source": "Amino acid substitution, fungal defensin analog, fungi-derived, natural derivatives",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "GFGCNGPWYEDDGRCHNHCKSIKGYKGGYCAKGGFVCKCY",
            "Sequence Length": 40,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-MRSA"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 4409.96,
            "PI": 8.61,
            "Hydrophobicity": -0.72,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Hao Y, Teng D, Mao R, Yang N, Wang J. 2023",
                    "Reference": "Antibiotics (Basel). 2023 Aug 3;12(8):1283. doi: 10.3390/antibiotics12081283.PubMed",
                    "Title": "Site Mutation Improves the Expression and Antimicrobial Properties of Fungal Defense."
                }
            ],
            "Frequent Amino Acids": "GCK",
            "Absent Amino Acids": "LMOQTU",
            "Basic Residues": 8,
            "Acidic Residues": 3,
            "Hydrophobic Residues": 11,
            "Polar Residues": 23,
            "Positive Residues": 8,
            "Negative Residues": 3,
            "Net Charge": 5,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (92.5%) toPlectasinActivity: Active against S. aureus 43300 MRSA or ATCC 25923 or E48 or 546 (MIC 1-16 ug/ml), S. epidermidis ATCC 35984 (MIC 16 ug/ml), S. hyicus 437-2 or NCTC 10350 (MIC 4-8 ug/ml), Streptococcus. suis CVCC 606 (MIC 1 ug/ml), S. agalactiae ATCC 13813 or CAU-FRI-4 (MIC 1-2 ug/ml), (MIC 1-16 ug/ml), (MIC 1-16 ug/ml), (MIC 1-16 ug/ml), (MIC 1-16 ug/ml), Gram- E.coli (MIC > 128 ug/ml), S.enterica ATCC 13076 (MIC > 128 ug/ml), S.enteritidis CVCC 3377 (MIC > 128 ug/ml), S.pullorum CVCC 1789 (MIC > 128 ug/ml), P.aeruginosa (MIC > 128 ug/ml), and C.albicans (MIC > 128 ug/ml).Antimicrobial robustness: activity is pH-insensitive (pH 2-10).Toxicity: not hemo.lytic up to 128 ug/ml.Recombinant production:yeast:Pichia pastoris: expressed and purified in a fermentor.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_26851",
                    "Similarity": 1.0,
                    "Sequence": "GFGCNGPWYEDDGRCHNHCKSIKGYKGGYCAKGGFVCKCY"
                },
                {
                    "SPADE_ID": "SPADE_N_09505",
                    "Similarity": 0.95,
                    "Sequence": "GFGCNGPWNEDDLRCHNHCKSIKGYKGGYCAKGGFVCKCY"
                },
                {
                    "SPADE_ID": "SPADE_N_14074",
                    "Similarity": 0.95,
                    "Sequence": "GFGCNGPWNEDDGKCHNHCKSIKGYKGGYCAKGGFVCKCY"
                }
            ]
        }
    }
}